Navigation Links
Study Suggests Soy Protein May Reduce Prostate Cancer Risk
Date:10/4/2007

ST. LOUIS, Oct. 4 /PRNewswire/ -- A study published in the Oct. 1 Journal of Nutrition suggests consumption of soy protein may play a role in reducing the risk of prostate cancer, Solae notes, giving consumers another healthy reason to make soy part of their diet.

The study, "Soy protein isolate increases urinary estrogens and the ratio of 2:16 alpha-hydroxyestrone in men at high risk of prostate cancer," is believed to be the first study investigating the effects of soy protein consumption on estrogen metabolism and prostate cancer in men.

"The intent of the study was to evaluate the effects of consuming soy protein on elimination of estrogen metabolites in the urine of men at a high risk for prostate cancer," said Dr. Mindy Kurzer, lead author of the study and a professor in the Department of Food Science and Nutrition at the University of Minnesota. "After taking biopsies of prostate tissue, androgen receptors were reduced in the prostate, which is consistent with a reduced risk of prostate cancer. In addition, significantly fewer of the men who consumed soy protein progressed to cancer by the end of the six-month study. We are encouraged by the results, but more studies must be performed."

"The results of this study could be beneficial for men who are at risk of prostate cancer," said Dr. Kathryn Greaves, Group Lead, Clinical Nutrition at Solae. "If the results of this study are replicated in future studies, reducing the risk of prostate cancer may be another reason to include soy in your daily diet."

Soy has been documented to potentially improve heart health and aid in sports performance and weight management. For more information on Solae and its products, please visit http://www.solae.com.

About Solae

Solae is the world leader in developing innovative soy-based technology to the food, meat and nutritional products industries. Solae provides solutions that deliver a un
'/>"/>

SOURCE Solae
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015 Research and Markets ... "Refurbished Medical Equipment Market - Global Forecasts to ... global refurbished medical equipment market is estimated to grow ... CAGR of 12.5% from 2014 to 2019. ... medical devices due to financial constraints, increasing privatization in ...
(Date:7/28/2015)... July 28, 2015 A German Diabetes Center ... L. reuteri probiotic enriches human gut microbiota and ... secretion.  The study involved daily administration of Nutraceutix,s ... using the patented BIO- tract ® delivery ... acid on their way to the intestinal tract. ...
(Date:7/28/2015)... July 28, 2015  SeraCare Life Sciences, a ... announced today at the American Association of Clinical ... licensing agreement with the University of California, San ... (T21), Trisomy 18 (T18) and Trisomy 13 (T13) ... creating "patient-like" reference materials for Non-Invasive Prenatal Testing ...
Breaking Medicine Technology:Refurbished Medical Equipment Market 2015 - Global Forecasts to 2019 2Nutraceutix's L. reuteri Probiotic Clinically Proven to Modulate Gut Insulin Metabolism 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 3
... Feb. 24, 2011 Reportlinker.com announces that a new ... Global Orthopedic Orthotics Industry ... the worldwide markets for Orthopedic Orthotics in US$ Million ... Ankle Braces, & Others) and Orthopedic Support Devices. The ...
... Sciences, Inc. (Nasdaq: CALP ), today announced ... the U.S. Environmental Protection Agency,s (EPA) ToxCast program have ... Key findings reported include (1) a high level of ... statistical analyses, and (2) the role that specific targets ...
Cached Medicine Technology:Reportlinker Adds Global Orthopedic Orthotics Industry 2Analysis of Caliper's Phase I EPA ToxCast™ Data Published in Leading Scientific Journal 2Analysis of Caliper's Phase I EPA ToxCast™ Data Published in Leading Scientific Journal 3
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... According to ... able to stop the cycle of addiction in lab mice. The study involving isradipine ... for the new prospect of helping their clients overcome drug and alcohol addictions. The ...
(Date:7/28/2015)... ... July 28, 2015 , ... According to WFTV ... taking the lead among heroin toxicity cases. According to recent statistic Orlando suffers at ... become known as a hub of heroin, and law enforcement officials are struggling to ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... the SmileCareClub Invisible Aligner System to its online product offerings, giving ... using a teledentistry model and cloud-based technology, SmileCareClub allows patients to get quality, ...
(Date:7/28/2015)... ... July 28, 2015 , ... A new ... workers than they are in the general population. Surviving Mesothelioma has just posted ... , Researchers at Taiwan’s National Health Research Institutes and three Taiwanese universities ...
(Date:7/28/2015)... ... 2015 , ... Fertility specialist Dr. Lisa Hasty of Atlanta Center ... Magazine. In Atlanta Magazine's annual Top Doctors issue, Dr. Hasty has been recognized for ... in the metro area as one of the most respected doctors in Reproductive Endocrinology. ...
Breaking Medicine News(10 mins):Health News:Blood Pressure Medication May be the Key to Treating Addiction 2Health News:Blood Pressure Medication May be the Key to Treating Addiction 3Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 2Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 3Health News:Brookstone Now Offers SmileCareClub Teeth Straightening System 2Health News:Brookstone Now Offers SmileCareClub Teeth Straightening System 3Health News:New Findings Suggest Mesothelioma is Not the Only Cancer Threat for Shipbreakers, According to Surviving Mesothelioma 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3
... Incorporated,(Nasdaq: GPRO ) announced today that the Company ... Wednesday, January 9, 2008 at,approximately 3:30 p.m. Pacific Time ... webcast live and may be accessed through a,link on ... . The webcast will be available for 30 days,following ...
... former Officer of Aetna, Inc., LOVELAND, Colo., ... today announced that Ms. Louise McCormick has joined ... ), "We pride ourselves on our commitment ... of high quality, independent Directors,is critical to this ...
... Antibodies to Fight Fatal Disease, LYON, ... division of sanofi-aventis Group, announced today that ... agreement with,Crucell N.V. (Euronext, NASDAQ: CRXL) for ... to be used in,association with rabies vaccine ...
... after calling emergency hotlines , , WEDNESDAY, Jan. 2 (HealthDay ... infectious disease outbreak may find themselves on hold with ... a new phone survey finds. , That hold ... researchers could not get through on at least one ...
... doctors say sunitinib,s benefits outweigh its risks , , WEDNESDAY, ... sunitinib (Sutent) can cause high blood pressure in patients ... echoes the results of a study published last month ... risk of heart failure among patients with stomach cancer. ...
... to help the poor, some experts say, , , WEDNESDAY, Jan. ... wealthy and insured patients, not to the poor and uninsured ... fact, more than four-fifths of those who receive samples are ... one-third have low incomes (below $37,000 for a family of ...
Cached Medicine News:Health News:Gen-Probe to Webcast Presentation at 26th Annual JPMorgan Healthcare Conference 2Health News:Louise McCormick Joins Heska's Board of Directors 2Health News:Louise McCormick Joins Heska's Board of Directors 3Health News:Sanofi Pasteur Enters Agreement With Crucell for Next-Generation Biologicals Against Rabies 2Health News:Sanofi Pasteur Enters Agreement With Crucell for Next-Generation Biologicals Against Rabies 3Health News:Sanofi Pasteur Enters Agreement With Crucell for Next-Generation Biologicals Against Rabies 4Health News:Health Departments Slow to Respond to Disease Outbreaks 2Health News:New Cancer Drug Boosts Blood Pressure 2Health News:New Cancer Drug Boosts Blood Pressure 3Health News:Most Free Drug Samples Go to Wealthy and Insured 2Health News:Most Free Drug Samples Go to Wealthy and Insured 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: